Managed Access Programs for INC280, Capmatinib
Novartis
Novartis
Taiho Oncology, Inc.
Cogent Biosciences, Inc.
Cogent Biosciences, Inc.
CG Oncology, Inc.
Karyopharm Therapeutics Inc
Autolus Limited
Endevica Bio
Janssen Scientific Affairs, LLC
Janssen Research & Development, LLC
AbbVie
USWM, LLC (dba US WorldMeds)
AbbVie
AbbVie
AbbVie
Takeda
AbbVie
xCures
NanOlogy, LLC
NanOlogy, LLC
Orca Biosystems, Inc.
ImmunityBio, Inc.
Regeneron Pharmaceuticals
NovoCure Ltd.
Nuvation Bio Inc.
Regeneron Pharmaceuticals
Novartis
Replimune Inc.
Janssen Research & Development, LLC
Celgene
Juno Therapeutics, a Subsidiary of Celgene
Aragon Pharmaceuticals, Inc.
Novartis
Janssen Research & Development, LLC
Novartis
Novartis
Novartis
Gilead Sciences
Regeneron Pharmaceuticals
Novartis
Regeneron Pharmaceuticals
Novartis
AVM Biotechnology Inc
Eli Lilly and Company
Hope Biosciences Research Foundation
Astellas Pharma Inc
Syndax Pharmaceuticals
Bristol-Myers Squibb
Leap Therapeutics, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited